These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21404895)

  • 1. Degeneration and atherosclerosis inducing increased deposition of type IIA secretory phospholipase A2, C-reactive protein and complement in aortic valves cause neutrophilic granulocyte influx.
    Kupreishvili K; Baidoshvili A; ter Weeme M; Huybregts MA; Krijnen PA; Van Hinsbergh VW; Stooker W; Eijsman L; Niessen HW
    J Heart Valve Dis; 2011 Jan; 20(1):29-36. PubMed ID: 21404895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation.
    ter Weeme M; Vonk AB; Kupreishvili K; van Ham M; Zeerleder S; Wouters D; Stooker W; Eijsman L; Van Hinsbergh VW; Krijnen PA; Niessen HW
    Eur J Clin Invest; 2010 Jan; 40(1):4-10. PubMed ID: 19843156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C4b-Binding Protein Deposition is Induced in Diseased Aortic Heart Valves, Coinciding with C3d.
    Dikhoff MJ; ter Weeme M; Vonk AB; Kupreishvili K; Blom AM; Krijnen PA; Stooker W; Niessen HW
    J Heart Valve Dis; 2015 Jul; 24(4):451-6. PubMed ID: 26897815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions.
    Skowasch D; Tuleta I; Steinmetz M; Pabst S; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2009 Jul; 18(4):411-7. PubMed ID: 19852145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density of Chlamydia pneumoniae is increased in fibrotic and calcified areas of degenerative aortic stenosis.
    Pierri H; Higuchi-dos-Santos MH; Higuchi Mde L; Palomino S; Sambiase NV; Demarchi LM; Rodrigues GH; Nussbacher A; Ramires JA; Wajngarten M
    Int J Cardiol; 2006 Mar; 108(1):43-7. PubMed ID: 15925417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.
    Skowasch D; Schrempf S; Preusse CJ; Likungu JA; Welz A; Lüderitz B; Bauriedel G
    Heart; 2006 Apr; 92(4):495-8. PubMed ID: 16159975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stenotic aortic valves have dysfunctional mechanisms of anti-inflammation: implications for aortic stenosis.
    Lee JH; Meng X; Weyant MJ; Reece TB; Cleveland JC; Fullerton DA
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):481-6. PubMed ID: 21241861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
    Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
    Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
    Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
    J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions.
    Kristen AV; Schnabel PA; Winter B; Helmke BM; Longerich T; Hardt S; Koch A; Sack FU; Katus HA; Linke RP; Dengler TJ
    Cardiovasc Pathol; 2010; 19(4):228-35. PubMed ID: 19502085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascending aortic aneurysms in unicommissural aortic valve disease.
    Butany J; Vaideeswar P; Dixit V; Lad V; Vegas A; David TE
    Cardiovasc Pathol; 2009; 18(1):11-8. PubMed ID: 18402825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
    Peltonen TO; Taskinen P; Soini Y; Rysä J; Ronkainen J; Ohtonen P; Satta J; Juvonen T; Ruskoaho H; Leskinen H
    Circulation; 2007 Sep; 116(11):1283-9. PubMed ID: 17709640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease.
    Wallby L; Steffensen T; Broqvist M
    Cardiovasc Pathol; 2007; 16(3):171-8. PubMed ID: 17502247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis.
    Ortlepp JR; Pillich M; Schmitz F; Mevissen V; Koos R; Weiss S; Stork L; Dronskowski R; Langebartels G; Autschbach R; Brandenburg V; Woodruff S; Kaden JJ; Hoffmann R
    J Heart Valve Dis; 2006 Jul; 15(4):502-8. PubMed ID: 16901043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.
    Mazzone A; Epistolato MC; De Caterina R; Storti S; Vittorini S; Sbrana S; Gianetti J; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
    J Am Coll Cardiol; 2004 May; 43(9):1670-6. PubMed ID: 15120829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in the aortic valve affect leaflet stress distributions: implications for aortic valve degeneration.
    Singh R; Strom JA; Ondrovic L; Joseph B; VanAuker MD
    J Heart Valve Dis; 2008 May; 17(3):290-8; discussion 299. PubMed ID: 18592926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease.
    Twardowski L; Cheng F; Michaelsen J; Winter S; Hofmann U; Schaeffeler E; Müller S; Sonnenberg M; Steuer K; Ott G; Schwab M; Franke UF; Torzewski M
    J Am Heart Assoc; 2015 Oct; 4(10):e002156. PubMed ID: 26475297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm.
    Lindeman JH; Abdul-Hussien H; Schaapherder AF; Van Bockel JH; Von der Thüsen JH; Roelen DL; Kleemann R
    Clin Sci (Lond); 2008 Jun; 114(11):687-97. PubMed ID: 18078385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N(omega)-(carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels.
    Baidoshvili A; Niessen HW; Stooker W; Huybregts RA; Hack CE; Rauwerda JA; Meijer CJ; Eijsman L; van Hinsbergh VW; Schalkwijk CG
    Atherosclerosis; 2004 Jun; 174(2):287-92. PubMed ID: 15136058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.